Applications of 17A-Methyl-1-Testosterone in Industrial Manufacturing

As a producer of 17A-Methyl-1-Testosterone, we supply this specialty raw material to select sectors requiring precision in synthesis, strict regulatory compliance, and careful process integration. Below are verified industrial downstream applications where this compound plays a specific functional role.

1. Active Pharmaceutical Ingredient (API) Synthesis for Androgenic Agents

Pharmaceutical manufacturers rely on 17A-Methyl-1-Testosterone to synthesize oral androgenic APIs for controlled therapeutic use. It enters GMP-controlled formulations where molecular stability, active purity, and traceability are mandatory throughout compounding and tableting. Only licensed medical API manufacturers incorporate this intermediate into downstream formulation lines, prioritizing full batch validation and cross-checking with pharmacopeial monographs for steroid hormones.

Industry compliance standards

• US FDA 21 CFR Part 210/211 cGMP for Drug Products
• United States Pharmacopeia (USP) Monograph for Androgens
• European Pharmacopoeia (Ph. Eur.) Chapter 5.8 for Hormonal Substances
• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients

Typical usage ratio

• API content usually ranges from 1 mg to 100 mg per finished tablet, adjusted according to the prescribed dosage form and regional regulatory limits.

Downstream process integration

• The material undergoes validated HPLC purity testing on receipt, dissolution in suitable solvents, granulation with excipients, blending, direct compression or encapsulation, and final packaging under GMP conditions.

Final product types

• Prescription androgen tablets
• Clinical trial batches for metabolic disorder research
• Reference standards for laboratory quality control

2. Reference Standard Production for Analytical Laboratories

Analytical reference standard manufacturers use 17A-Methyl-1-Testosterone as a certified primary material for calibration and QC checks in pharmaceutical and forensic laboratories. Precision weighing, purity verification by HPLC, and accurate documentation remain essential to ensure standards meet international calibration requirements. Accredited facilities process and distribute calibrated ampoules, supporting residue testing, bioanalysis, and instrument validation protocols globally.

Industry compliance standards

• ISO 17034 General Requirements for the Competence of Reference Material Producers
• ISO/IEC 17025 Laboratory Accreditation
• USP General Chapter <922> for Reference Standards

Typical usage ratio

• Packing concentrations of 1–10 mg per ampoule or vial, with concentration selected per end-user laboratory protocol and instrument sensitivity needs.

Downstream process integration

• The compound is dissolved and diluted to certified concentrations, aliquoted into ampoules under nitrogen to prevent oxidation, and undergoes batch-specific homogeneity and stability testing before release.

Final product types

• HPLC and GC calibration standards
• Analytical control kits
• External quality assurance samples for forensic and pharmaceutical labs

3. Steroid Intermediate for Veterinary Drug Formulations (Non-food Producing Animal Use)

Veterinary pharmaceutical manufacturers incorporate 17A-Methyl-1-Testosterone as an intermediate for research and development of steroid-based treatments in non-food-producing animals. Regulatory oversight prohibits its application in food animal production. Its use remains confined to licensed R&D environments concerned with animal physiology studies, endocrine disorder modeling, and investigational formulations where strict batch control and animal welfare compliance prevail.

Industry compliance standards

• VICH GL9 Good Clinical Practice for Veterinary Medicinal Products
• FDA 21 CFR Part 558: New Animal Drugs for Use in Animal Feeds (non-food animals)
• OECD Guidelines for the Testing of Chemicals (Veterinary Studies)

Typical usage ratio

• Microgram to milligram-level inclusion per dose, with precise concentration controlled by animal weight and study protocol under institutional animal care guidelines.

Downstream process integration

• The compound enters sterile compounding suites, dissolves in suitable veterinary excipients, then follows strict batch record-keeping and labeling for R&D or investigational use only.

Final product types

• Investigational veterinary steroid injectable solutions (non-commercial use)
• R&D oral formulations for laboratory animal studies
• Physiological study test kits

4. Bulk Compound for Controlled Scientific Research Supply

Specialized academic and contract research organizations source 17A-Methyl-1-Testosterone for controlled research and method development, particularly for metabolic, endocrine, and receptor-binding studies. Accredited supply channels observe chain-of-custody documentation, research-use-only labeling, and custom packaging that meets legal and export control restrictions. Strict documentation procedures and secure storage chronicle all movement from receipt through consumption within authorized labs.

Industry compliance standards

• OECD Good Laboratory Practice (GLP)
• Institutional Biosafety Committee (IBC) Approval Procedures
• Country-specific precursor chemical regulations

Typical usage ratio

• Stock solutions typically prepared at 0.1–5 mg/mL concentration, adjusted as required for the particular bioassay protocol or analytical technique in use.

Downstream process integration

• Material dissolves in research-grade solvents and integrates at the initial assay preparation step. Each aliquot maintains traceability via electronic laboratory notebooks, matching material identity to experimental records.

Final product types

• Preclinical assay plates
• Binding affinity research panels
• Molecular mechanism exploration samples for peer-reviewed publication